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Abstract 
Neuropeptide Y receptors are critical regulators of energy homeostasis and are well known 
for their powerful influence on feeding, but their roles in other important aspects of energy 
homeostasis, such as energy expenditure and their functional interactions in these processes, 
are largely unknown. Here we show that mice lacking both Y2 and Y4 receptors exhibited a 
reduction in adiposity, more prominent in intra-abdominal vs. subcutaneous fat, and an 
increase in lean mass as determined by dual-energy X-ray absorptiometry. These changes 
were more pronounced than those seen in mice with Y2 or Y4 receptor single deletion, 
demonstrating the important roles and synergy of Y2 and Y4 signaling in the regulation of 
body composition. These changes in body composition occurred without significant changes 
in food intake, but energy expenditure and physical activity were significantly increased in 
Y4−/− and particularly in Y2−/−Y4−/− but not in Y2−/− mice, suggesting a critical role of Y4 
signaling and synergistic interactions with Y2 signaling in the regulation of energy expenditure 
and physical activity. Y2−/− and Y4−/− mice also exhibited a decrease in respiratory 
exchange ratio with no further synergistic decrease in Y2−/−Y4−/− mice, suggesting that Y2 
and Y4 signaling each play important and independent roles in the regulation of substrate 
utilization. The synergy between Y2 and Y4 signaling in regulating fat mass may be related to 
differences in mitochondrial oxidative capacity, since Y2−/−Y4−/− but not Y2−/− or Y4−/− 
mice showed significant increases in muscle protein levels of peroxisome proliferator-
activated receptor (PPAR)γ coactivator (PGC)-1α, and mitochondrial respiratory chain 
complexes I and III. Taken together, this work demonstrates the critical roles of Y2 and Y4 
receptors in the regulation of body composition and energy metabolism, highlighting dual 
antagonism of Y2 and Y4 receptors as a potentially effective anti-obesity treatment. 
 
 
Neuropeptide y (NPY), a 36-amino acid peptide expressed in the central and peripheral 
nervous system, plays a critical role in regulating energy homeostasis. An increase in 
hypothalamic NPY-ergic tone elicits robust hyperphagia, decreases energy expenditure, and 
induces many endocrine and metabolic changes that ultimately lead to excessive weight gain 
and fat gain (22, 23, 27, 36, 42, 50). NPY exerts its effects through activation of the G protein-
coupled Y receptors, notably Y1, Y2, Y4, Y5, and y6 (8). Interestingly, whereas much work 
has focused on mechanisms underlying NPY-induced hyperphagia, few studies have 
examined the relative contribution and functional interactions of Y receptors in regulating 
energy expenditure, the other side of the energy balance equation. Energy expenditure is an 
important component of energy balance since excessive fat gain in response to central 
elevation of NPY persists even when NPY-induced hyperphagia is prevented by pair feeding, 
demonstrating that NPY regulates adiposity independent of food intake, and that aspects of 
energy homeostasis other than feeding play a pivotal role in NPY's obesogenic effects (42, 
55). Moreover, low energy expenditure predicts subsequent weight gain in humans (17, 35), 
demonstrating the relevance of mechanisms regulating energy expenditure to human health. 
 Y2 and Y4 receptors have been shown to play an important role in the regulation of 
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adiposity, with pronounced synergies between Y2 and Y4 signaling on fat mass as 
demonstrated using germline knockout mice (26, 40, 41, 43, 44). While germline knockout 
models can show developmental adaptations to gene deletion that may mask primary effects 
of the gene deletion (31), they are a useful experimental tool for identifying key players in 
physiological processes, such as energy homeostasis. Thus, mice that lack Y4 and/or Y2 
receptors had reduced fat mass with a greater reduction in fat mass observed in mice with 
germline Y2 and Y4 double deletions (40). This marked reduction in fat mass in Y2 and Y4 
double knockouts was associated with significant decreases in circulating insulin and leptin 
levels in the nonfasted state (41). Interestingly, massive obesity in leptin-deficient ob/ob mice 
is attenuated by Y2 (44) but not by Y4 (45) receptor deletion, suggesting different 
mechanisms and capacity of Y2 and Y4 signaling in the control of adiposity. Importantly, dual 
deletion of Y2 and Y4 receptors in ob/ob mice produced marked reductions in body weight 
and fat mass that were more pronounced than those observed in ob/ob mice with Y2 receptor 
single deletion (26). This finding demonstrates that the synergistic effects of Y2 and Y4 
receptor ablation on adiposity observed on a lean background prevail in the massively obese 
ob/ob background. 
 Despite this compelling evidence that dual antagonism of Y2 and Y4 signaling may 
provide potent anti-obesity benefits, the mechanisms underlying the individual control and 
synergistic interactions between Y2 and Y4 signaling in the regulation of adiposity and energy 
homeostasis are unclear. Changes in the activity of several hypothalamopituitary axes may 
be involved in the regulation of body composition and energy metabolism by Y2 and Y4 
signaling. For instance, germline Y2 or Y4 receptor knockout reduces expression of 
corticotropin-releasing hormone mRNA in the paraventricular nucleus of the hypothalamus in 
association with a tendency for decreased serum corticosterone concentrations on a lean 
background and normalization of hypercorticosteronemia of ob/ob mice (26, 40, 44, 45). In 
addition to modulating output from the hypothalamo-pituitary-adrenal axis, Y2 signaling has 
been shown to mediate responses to glucocorticoids, since the obesity syndrome induced by 
exogenous corticosterone administration to wild-type mice is abolished in mice lacking Y2 
signaling (43). Ablation of Y2 signaling abolishes fasting-induced reduction in the activity of 
somatotropic axis (29) and restores the low-serum IGF-1 levels in ob/ob mice (44), 
suggesting a role of Y2 signaling in regulating activity of the somatotropic axis, activation of 
which is known to promote the accretion of lean mass at the expense of fat mass (19). On the 
other hand, lack of Y4 signaling eliminates fasting-induced inhibition on the gonadotropic axis 
(29) and restores the low testosterone levels and fertility of ob/ob mice (45), indicating Y4 
signaling may regulate energy metabolism via redistributing energy toward reproductive 
function. Surprisingly, changes in the activity of somatotropic and gonadotropic axes induced 
by Y2 and Y4 single deletion were not detected in nonfasted mice lacking both Y2 and Y4 
receptors on a lean (40) or ob/ob background (26), suggesting that mechanisms other than 
changes in somatotropic and gonadotropic axis function may be involved in the synergistic 
control of energy balance by Y2 and Y4 signaling. 
 Whether altered food intake contributes to the lean phenotype of mice with single or 
double Y2 and Y4 receptor deletion is not clear. Earlier studies on food intake in these mice 
were conducted at various ages (8, 12, or 16 wk of age), with food spillage not being adjusted 
for in the majority of studies (41, 43–45). Interestingly, however, several lines of evidence 
suggest an involvement of Y2 and Y4 signaling in the control of energy expenditure. Indeed, 
the expression of thyrotrophin-releasing hormone mRNA in the paraventricular nucleus of the 
hypothalamus is increased in mice lacking Y4 or Y2 and Y4 receptors (40), suggesting a role 
of Y4 signaling in the control of thyroid function, an important determinate of energy 
expenditure (6, 48). Furthermore, the expression of uncoupling protein-1 in brown adipose 
tissue, an important regulator of thermogenesis and energy expenditure (24), is markedly 
decreased in ob/ob mice but is restored by Y2 receptor deletion (44). However, thyroid 
function and uncoupling protein-1 expression are indirect estimates of energy expenditure, 
and the control of energy expenditure by Y2 and Y4 signaling and the functional interaction of 
these two pathways in this process are thus unknown. 
To allow direct and definitive investigation of the individual control and functional interaction 
between Y2 and Y4 signaling in the regulation of energy metabolism, we examined food 
intake in mice with single or double deletion of Y2 and Y4 receptors at a uniform age and 
accounted for spillage, which was recently shown to be significantly altered by Y receptor 
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ablation (3, 41). We also employed indirect calorimetry to study the effects of single or double 
deletion of Y2 and Y4 receptors on energy expenditure as well as substrate oxidation, 
combined with measurement of physical activity and body composition. Furthermore, we 
examined the expression of key molecules involved in mitochondrial oxidation that may be 
mechanistically involved in the coordinated regulation of energy expenditure and substrate 
utilization by Y2 and Y4 signaling. 
 
EXPERIMENTAL PROCEDURES 
 
Animals. 
All research and animal care procedures were approved by the Garvan Institute/St. Vincent's 
Hospital Animal Ethics Committee and were in agreement with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purpose. Mice were housed under 
conditions of controlled temperature (22°C) and illumination (12-h light cycle, lights on at 
07:00). All mice were fed a normal chow diet ad libitum (8% calories from fat, 21% calories 
from protein, 71% calories from carbohydrate, and 2.6 kcal/g; Gordon's Specialty Stock 
Feeds, Yanderra, NSW, Australia). Details of generation of the germline Y2 and Y4 receptor 
single and double-knockout mice have been previously published (40, 43, 45). Briefly, 
targeting constructs were designed that contain loxP flanking sequence upstream and 
downstream of the single coding exons of the Y2 and Y4 genes, respectively. After Cre-
mediated recombination, this allows for the generation of null mice that do not contain any 
coding sequence including the translation start codon, thereby preventing any interference 
from minor remaining transcripts. Germline deletion of Y2 and Y4 receptor genes was 
achieved by crossing conditional-knockout floxed mice (Y2lox/lox or Y4lox/lox) with oocyte-
specific Cre recombinase-expressing C57BL/6 mice. Y2−/−Y4−/− double-knockout mice were 
obtained by crossing Y2−/− and Y4−/− mice. All mice were on a mixed C57BL/6–129/SvJ 
background. 
 
Food intake. 
Food intake was measured in male Y2−/−, Y4−/−, and Y2−/−Y4−/− and wild-type mice at 11 
wk of age. Mice were transferred from group housing on soft bedding to individual cages with 
paper towel bedding and allowed to acclimatize for 3 days. Food intake was determined as 
the averages of triplicate readings taken over three consecutive days. Actual food intake was 
calculated as the weight of pellets taken from the food hopper minus the weight of food 
spillage in the cage. Fecal weight was also determined in triplicate during these analyses. 
 
Indirect calorimetry. 
Studies of indirect calorimetry were carried out on male Y2−/−, Y4−/−, Y2−/−Y4−/− and wild-
type mice at 14–15 wk of age as described previously (56). Briefly, metabolic rate was 
measured by indirect calorimetry using an eight-chamber open-circuit calorimeter (Oxymax 
Series; Columbus Instruments, Columbus, OH). Preweighed mice were housed individually in 
specially built Plexiglas cages (20.1 × 10.1 × 12.7 cm). Temperature was maintained at 22°C 
with airflow of 0.6 l/min. Food and water were available ad libitum. Mice were singly housed 
for 3 days prior to transferring into the calorimeter cages and were acclimatized to the cages 
for 24 h before recordings commenced. Mice were subsequently monitored in the system for 
24 h. Oxygen consumption (V̇o2) and carbon dioxide production (V̇co2) were measured every 27 
min. The respiratory exchange ratio (RER) was calculated as the quotient of V̇co2/V̇o2, with 100% 
carbohydrate oxidation resulting in an RER of 1 and 100% fat oxidation resulting in an RER of 
0.7 (15, 16). Energy expenditure (kcal heat produced) was calculated as Calorific Value (CV) × V̇o2, 
where CV is 3.815+1.232 × RER (34). Data for the 24-h monitoring period was averaged for 
1-h intervals for energy expenditure (kcal/h) and RER. 
 
Measurement of physical activity. 
Physical activity was recorded continuously by infrared beam sensors using an OPTO-M3 
sensor system with a 60-s data download interval (Columbus Instruments, Columbus, OH) at 
the same time as the indirect calorimetry measurements. This system provides both total 
counts (every time a beam is broken) and ambulatory counts (when a consecutive adjacent 
beam is broken) in the x- and y-axes directions. The recording of ambulatory counts does not 
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include the same beam being broken repeatedly and thus measures actual locomotion. 
Therefore, ambulatory counts in the x- and y-axes directions were used to measure physical 
activity, and continuous recording of individual mouse data were summed for 1-h intervals. 
To estimate resting metabolic rate and determine the possible contribution of changes in 
physical activity to changes in energy expenditure, a correlation analysis between physical 
activity and energy expenditure was performed as described previously (7). Briefly, each 1-h 
point of physical activity was plotted against the corresponding 1-h point of energy 
expenditure, and the correlation analysis was based on data collected over 24 h in individual 
mice. The function of the trend line was extrapolated to set the physical activity to zero and 
the x-axis intercept was used as an estimate of resting metabolic rate. 
 
Analysis of body composition. 
Upon completion of indirect calorimetry and physical activity measurements, animals were 
anesthetized with isoflurane and then subjected to dual-energy X-ray absorptiometry (DXA; 
Lunar PIXImus2 mouse densitometer; GE Healthcare, Waukesha, WI) to determine whole 
body fat mass and nonfat, nonbone mass. Nonfat, nonbone mass is referred to as lean mass 
in the manuscript for easier presentation. The head and the tail were excluded from the 
analysis of body composition. 
 
Tissue collection. 
Upon completion of the study, mice at 15 wk of age were culled between 12:00 and 15:00 h 
by cervical dislocation followed by decapitation. White adipose tissue depots (inguinal, 
epididymal retroperitoneal, and mesenteric) were removed and weighed. The quadriceps 
skeletal muscles were frozen until further analysis by Western blotting as described below. 
 
Western blot analysis. 
Western blot analysis was performed on quadriceps muscle samples following procedures 
described previously (56) to determine protein levels of key enzymes involved in 
mitochondrial oxidation. Briefly, powdered muscle samples were resuspended in 
radioimmunoprecipitation assay buffer (PBS, pH 7.5; 1% nonident NP-40; 0.5% sodium 
deoxy-cholate; and 0.1% SDS) supplemented with protease and phosphatase inhibitors (10 
μg/ml PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mmol/l Na3VO4, and 10 mmol/l NaF) 
and solubilized for 2 h at 4°C. Equal amounts of tissue lysate (20 μg protein) were resolved 
by SDS-PAGE and immunoblotted with anti-bodies against peroxisome proliferator-activated 
receptor (PPAR)-γ coactivator (PGC)-1α (Calbiochem, Merck, Kilsyth VIC, Australia), 
carnitine palmitoyltransferase-1 (CPT-1; Alpha Diagonistic San Antonio, TX), or an anti-body 
cocktail that recognizes several subunits of the mitochondrial respiratory chain (cat. no. 
MS601; Mitosciences, Eugene, OR). Immunolabeled bands were quantified by densitometry. 
Relative protein levels of the mutant mice as a percentage of that of control mice are 
presented. 
 
Statistical analyses. 
All data are expressed as means ± SE. RER and physical activity over the continuous 24-h 
period were averaged for the whole 24-h period, as well as for the light and dark periods. 
Differences between knockout and wild-type mice were assessed by ANOVA or repeated-
measures ANOVA. Comparisons of energy expenditure (kcal/h) were carried out by ANCOVA 
with lean body mass as covariate, and the slopes of the regression lines were compared by a 
test of homogeneity of slopes by ANCOVA. Subsequent multiple post hoc comparisons were 
performed via the method of Bonferroni and the adjusted means of energy expenditure at a 
common lean mass were generated by ANCOVA. Equality of variance between groups was 
tested with the Levene's test. Statistical analyses were performed with SPSS for Mac OS X, 
version 16.0.1 (SPSS, Chicago, IL). Statistical significance was defined as P < 0.05. 
 
RESULTS 
 
Synergistic reduction in adiposity and increase in lean (nonfat, nonbone) tissue mass in 
response to double deletion of Y2 and Y4 receptors with no decrease in food intake. 
Body weight of Y2−/−Y4−/− mice was no different from that of wild-type mice, while Y2−/− 
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and Y4−/− mice weighed significantly less than wild types (Table 1). Importantly, however, 
mice with single or double deletion of Y2 and Y4 receptors exhibited a lean phenotype, with 
Y2−/−Y4−/− mice being the leanest. Thus, whereas the epididymal white adipose tissue mass 
relative to body weight was significantly reduced in all knockouts compared with wild types, 
the reduction in weight of this tissue was significantly greater in Y2−/−Y4−/− than that in 
Y2−/− or Y4−/− mice (Fig. 1A). This pattern of changes in adiposity among wild-type, Y2, and 
Y4 single or double knockouts exists in other dissected white adipose depots, namely the 
mesenteric, retroperitoneal, and inguinal white adipose tissue depots (Fig. 1A), and is also 
apparent when adiposity was expressed as the summed weight of these dissected white 
adipose depots (Fig. 1B) as well as whole body fat mass as determined by DXA scan (Fig. 
1C). The absolute weights of individual and summed dissected white adipose tissues as well 
as whole body fat mass as determined by DXA in wild-type, Y2−/−, Y4−/−, and Y2−/−Y4−/− 
mice (Table 1) showed similar differences to those seen when fat masses were expressed as 
relative weights (Fig. 1, A–C). These results suggest a synergy between Y2 and Y4 receptor 
signaling in the regulation of adiposity. Importantly, the ratio of the summed weight of the 
intraperitoneal white adipose tissue depots measured (epididymal, mesenteric, and 
retroperitoneal) vs. that of the subcutaneous depot measured (inguinal) was significantly 
reduced in Y2−/−Y4−/− but not in Y2−/− or Y4−/− mice compared with wild-type mice (Table 
1), suggesting more prominent effects of the Y2 and Y4 synergistic interaction on intra-
abdominal vs. subcutaneous fat depots. Furthermore, the whole body nonfat, nonbone mass 
(hereafter referred to as lean tissue mass) as determined by DXA was significantly increased 
in Y2−/−Y4−/− and to a lesser extent in Y4−/− mice (Fig. 1D), suggesting also a synergy 
between Y2 and Y4 signaling in the regulation of lean tissue mass. In conjunction with the 
comparable body weight between wild-type and Y2−/−Y4−/− mice (Table 1), the synergistic 
reduction in fat mass (Fig. 1, A–C) and the concomitant increase in lean tissue mass (Fig. 
1D) in Y2−/−Y4−/− double-knockout mice suggests formation of lean tissue mass at the 
expense of fat mass in these animals. Interestingly, daily food intake was not significantly 
different among different genotypes, albeit there was a trend toward decreased food intake in 
Y2−/− and Y4−/− mice and a more apparent trend toward increased food intake in 
Y2−/−Y4−/− mice relative to wild types (3.47 ± 0.24, 3.19 ± 0.11, 3.21 ± 0.18, and 4.06 ± 0.16 
g/day for wild-type, Y2−/−, Y4−/−, and Y2−/−Y4−/− mice, respectively, data are means ± SE 
of 6–10 mice per group at 14–15 wk of age measured over 3 consecutive days, not 
significant). Furthermore, daily fecal output was similar among groups, with a trend toward 
increased output in Y2−/−Y4−/− mice, in keeping with the food intake in these mice [0.926 ± 
0.14, 0.856 ± 0.06, 0.862 ± 0.09 and 1.08 ± 0.10 g (wet wt)/day for wild-type, Y2−/−, Y4−/−, 
and Y2−/−Y4−/− mice, respectively, data are means ± SE of 6–10 mice per group at 14–15 
wk of age, not significant]. 
	  
	  	  	  
To estimate resting metabolic rate and determine the possible contri-
bution of changes in physical activity to changes in energy expenditure,
a correlation analysis between physical activity and energy expenditure
was performed as described previously (7). Briefly, each 1-h point of
physical activity was plotted against the corresponding 1-h point of
energy expenditure, and the correlation analysis was based on data
collected over 24 h in individual mice. The function of the trend line was
extrapolated to set the physical activity to zero and the x-axis intercept
was used as an estimate of resting metabolic rate.
Analysis of body composition. Upon completion of indirect calo-
rimetry and physical activity measurements, animals were anesthe-
tized with isoflurane and then subjected to dual-energy X-ray absorp-
tiometry (DXA; Lunar PIXImus2 mouse densitometer; GE Health-
care, Waukesha, WI) to determine whole body fat mass and nonfat,
nonbone mass. Nonfat, nonbone mass is referred to as lean mass in the
manuscript for easier presentation. The head and the tail were ex-
cluded from the analysis of body composition.
Tissue collection. Upon completion of the study, mice at 15 wk of
age were culled between 12:00 and 15:00 h by cervical dislocation
followed by decapitation. White adipose tissue depots (inguinal,
epididymal retroperitoneal, and mesenteric) were removed and
weighed. The quadriceps skeletal muscles were frozen until further
analysis by Western blotting as described below.
Western blot analysis. Western blot analysis was performed on
quadriceps muscle samples following procedures described previ-
ously (56) to determine protein levels of key enzymes involved in
mitochondrial oxidation. Briefly, powdered muscle samples were
resuspended in radioimmunoprecipitati n assay buffer (PBS, pH 7.5;
1% nonident NP-40; 0.5% sodium deoxy-cholate; and 0.1% SDS)
supplemented with protease and phosphatase inhibitors (10 !g/ml
PMSF, 10 !g/ml aprotinin, 10 !g/ml leupeptin, 1 mmol/l Na3VO4,
and 10 mmol/l NaF) and solubilized for 2 h at 4°C. Equal amounts of
tissue lysate (20 !g protein) were resolved by SDS-PAGE and
immunobl tted with anti- dies against peroxisome proliferator-acti-
vated receptor (PPAR)-" coactivator (PGC)-1# (Calbiochem, Merck,
Kilsyth VIC, Australia), carnitine palmitoyltransferase-1 (CPT-1; Al-
pha Diagonistic San Antonio, TX), or an anti-body cocktail that
recognizes several subunits of the mitochondrial respiratory chain
(cat. no. MS601; Mitoscie ces, Eugene, OR). Immunolabeled bands
were quantified by densitometry. Relative protein levels of the mutant
mice as a percentage of that of control mice are presented.
Statistical analyses. All data are expressed as means $ SE. RER
and physical activity over the continuous 24-h period were averaged
for the whole 24-h period, as well as for he light and dark periods.
Differences between knockout and wild-type mice were assessed by
ANOVA or repeated-measures ANOVA. Comparisons of energy
expenditure (kcal/h) were carried out by ANCOVA with lean body
mass as covariate, and the slopes of the regression lines were com-
pared by a test of homogeneity of slopes by ANCOVA. Subsequent
multiple post hoc comparisons were performed via the method of
Bonferroni and the adjusted means of energy expenditure at a com-
mon lean mass were generated by ANCOVA. Equality of variance
between groups was tested with the Levene’s test. Statistical analyses
were performed with SPSS for Mac OS X, version 16.0.1 (SPSS,
Chicago, IL). Statistical significance was defined as P % 0.05.
RESULTS
Synergistic reduction in adiposity and increase in lean
(nonfat, nonbone) tissue mass in response to double deletion of
Y2 and Y4 receptors with no decrease in food intake. Body
weight of Y2&/&Y4&/& mice was no different from that of
wild-type mice, while Y2&/& and Y4&/& mice weighed signif-
icantly less than wild types (Table 1). Importantly, however,
mice with single or double deletion of Y2 and Y4 receptors
exhibited a lean phenotype, with Y2&/&Y4&/& mice being the
leanest. Thus, whereas the e ididymal white adipose tissue
mass relative to body weight was significantly reduced in all
knockouts compared with wild types, the reduction in weight
of this tissue was significantly greater in Y2&/&Y4&/& than that
in Y2&/& or Y4&/& mice (Fig. 1A). This pattern of changes in
adiposity among wild-type, Y2, and Y4 single or double
knockouts exists in other dissected white adipose depots,
namely the mesenteric, retroperitoneal, and inguinal white
adipose tissue depots (Fig. 1A), and is also apparent when
adiposity was xpressed as the summed weight of these dis-
sected white adipose depots (Fig. 1B) as well as whole body fat
mass as determined by DXA scan (Fig. 1C). The absolute
weights of individual and summed dissected white adipose
tissues as well as whole body fat mass as determined by DXA
in wild-type, Y2&/&, Y4&/&, and Y2&/&Y4&/& mice (Table 1)
showed similar differences to those seen when fat masses were
expressed as relative weights (Fig. 1, A–C). These results
suggest a synergy between Y2 and Y4 receptor signaling in the
regulation o adiposity. Importa tly, the ratio of the summed
weight of the intraperitoneal white a ip se tissue d pots mea-
sured (epididymal, mesenteric, and retroperitoneal) vs. that of
the subcutaneous depot measured (inguinal) was significantly
reduced in Y2&/&Y4&/& but not in Y2&/& or Y4&/& mice
compared with wild-type mice (Table 1), suggesting more
prominent effects of the Y2 and Y4 synergistic interaction on
intra-abdominal vs. subcutaneous fat depots. Furthermore, the
whole body nonfat, nonbone mass (hereafter referred to as lean
tissue mass) as determined by DXA was significantly increased
in Y2&/&Y4&/& and to a lesser xtent in Y4&/& mice (Fig. 1D),
suggesting also a synergy between Y2 and Y4 signaling in the
Table 1. Effects of single or double deletion of Y2 and Y4 receptors on body weight and adiposity
Wild Type Y2&/& Y4&/& Y2&/&Y4&/&
Body weight 25.2 $ 0.7 22.9 $ 0.7* 21.3 $ 0.4* 25.5 $ 0.6
Epididymal white adipose tissue 0.544 $ 0.03 0.370 $ 0.03† 0.255 $ 0.01†‡ 0.160 $ 0.004†‡
Mesenteric white adipose tissue 0.271 $ 0.03 0.216 $ 0.01 0.1542 $ 0.01* 0.131 $ 0.01*
Retroperitoneal white adipose tissue 0.151 $ 0.01 0.083 $ 0.01† 0.047 $ 0.003† 0.037 $ 0.002†‡
Inguinal white adipose tissue 0.545 $ 0.04 0.360 $ 0.02† 0.232 $ 0.01†‡ 0.251 $ 0.02†
Summed weight of measured white adipose tissue depots 1.51 $ 0.1 1.03 $ 0.06† 0.688 $ 0.03†‡ 0.579 $ 0.03†‡
Intra-abdominal-to-subcutaneous fat ratio 1.81 $ 0.08 1.88 $ 0.10 2.00 $ 0.11 1.33 $ 0.07*‡§
Whole body fat mass 3.60 $ 0.23 3.00 $ 0.16 2.21 $ 0.10† 2.45 $ 0.08†
Data are means $ SE of 6–10 mice per group in grams. Data were collected from mice at 14–15 wk of age. Whole body fat mass was determined by X-ray
absorptiometry. The ratio of the summed weight of the intraperitoneal depots measured (epididymal, mesenteric, and retroperitoneal) vs. that of the subcutaneous
depot measured (inguinal) is used as an indicator of intra-abdominal-to-subcutaneous fat ratio. *P % 0.05 and †P % 0.001 vs. wild type mice; ‡P % 0.05 vs.
Y2&/& mice; §P % 0.05 vs. Y4&/& mice.
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Synergistic increase in energy expenditure by double deletion of Y2 and Y4 receptors. 
To investigate mechanisms underlying the synergistic control of adiposity and lean mass by 
Y2 and Y4 receptors, we examined energy expenditure, the other side of the energy balance 
equation, and RER, an index of oxidative fuel source, by indirect calorimetry with concurrent 
measurement of physical activity in wild-type, Y2−/−, Y4−/−, and Y2−/−Y4−/− mice. 
Since energy expenditure is, in part, determined by body size, we normalized energy 
expenditure via ANCOVA (Fig. 2) to account for differences in lean tissue mass, the best 
determinant of energy expenditure (37) (see Table 2 for nonnormalized energy expenditure 
data). Energy expenditure followed a circadian rhythm in all groups, with higher energy 
expenditure in the dark period (Fig. 2A). Y2−/− mice had similar daily energy expenditure to 
wild types, with a slight decrease in energy expenditure during the light period (Fig. 2, A and 
B). In contrast, Y4−/− mice showed a significant increase in energy expenditure compared 
with wild-type mice during the dark period (Fig. 2, A and B). Interestingly, mice with double 
deletion of Y2 and Y4 receptors showed a marked increase in overall energy expenditure, 
which is significant during the dark period (Fig. 2, A and B). Importantly, the energy 
expenditure of Y2−/−Y4−/− mice in the dark phase was not only significantly higher than that 
regulation of lean tissue mass. In conjunction with the compa-
rable body weight between wild-type and Y2!/!Y4!/! mice
(Table 1), the synergistic reduction in fat mass (Fig. 1, A–C)
and the concomitant increase in lean tissue mass (Fig. 1D) in
Y2!/!Y4!/! double-knockout mice suggests formation of
lean tissue mass at the expense of fat mass in these animals.
Interestingly, daily food intake was not significantly iffer nt
among different genotypes, albeit there was a trend toward
decreased food intake in Y2!/! and Y4!/! mice and a more
apparent trend toward increased food intake in Y2!/!Y4!/!
mice relative to wild types (3.47 " 0.24, 3.19 " 0.11, 3.21 "
0.18, and 4.06 " 0.16 g/day for wild-type, Y2!/!, Y4!/!, and
Y2!/!Y4!/! mice, spectively, data a e means" SE of 6–10
mice per group at 14–15 wk of age measured over 3 consec-
utive days, not significant). Furthermore, daily fecal output was
similar among groups, with a trend toward increased output in
Y2!/!Y4!/! mice, in keeping with the food intake in these mice
[0.926 " 0.14, 0.856 " 0.06, 0.862 " 0.09 and 1.08 " 0.10 g
(wet wt)/day for wild-type, Y2!/!, Y4!/!, and Y2!/!Y4!/!
mice, respectively, data are means" SE of 6–10 mice per group
at 14–15 wk of age, not significant].
Synergistic increase in energy expenditure by double dele-
tion of Y2 and Y4 receptors. To investigate mechanisms un-
derlying the synergistic control of adiposity and lean mass by
Y2 and Y4 receptors, we examined energy expenditure, the
oth r side of the energ balance equation, and RER, an index
Fig. 1. Synergy between Y2 and Y4 receptors in the
regulation of body composition. Mass of individual
white adipose depots (A), namely epididymal (WATe),
mesenteric (WATm), retroperitoneal (WATr), ingui-
nal (WATi), and combined weight of these depots (B)
as % body weight in wild-type (WT), Y2!/!, Y4!/!,
and Y2!/!Y4!/! mice. Whole body fat mass (C) and
nonfat, nonbone mass defined as lean mass (D) relative
to body weight determined by dual-energy X-ray
absorptiometry (DXA) in WT, Y2!/!, Y4!/!, and
Y2!/!Y4!/! mice. Data are means " SE from 6–10
mice/group. *P # 0.05, **P # 0.001 vs. WT mice or
comparison indicated by horizontal bars.
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of wild types, also it was significantly higher than that of Y2−/− and Y4−/− mice (Fig. 2, A and 
B), suggesting a synergy between Y2 and Y4 signaling in the regulation of energy 
expenditure, which may contribute to their synergistic effects on adiposity. 
 
 
 
	  	  	  	  
	  	  
 
 
of oxidative fuel source, by indirect calorimetry with concur-
rent measurement of physical activity in wild-type, Y2!/!,
Y4!/!, and Y2!/!Y4!/! mice.
Since energy expenditure is, in part, determined by body
size, we normalized energy expenditure via ANCOVA (Fig. 2)
to account for differences in lean tissue mass, the best deter-
minant of energy expenditure (37) (see Table 2 for nonnormal-
ized energy expenditure data). Energy expenditure followed a
circadian rhythm in all groups, with higher energy expenditure
in the dark period (Fig. 2A). Y2!/! mice had similar daily
energy expenditure to wild types, with a slight decrease in
energy expenditure during the light period (Fig. 2, A and B). In
contrast, Y4!/! mice showed a significant increase in energy
expenditure compared with wild-type mice during the dark
period (Fig. 2, A and B). Interestingly, mice with double
deletion of Y2 and Y4 receptors showed a marked increase in
overall energy expenditure, which is significant during the dark
period (Fig. 2, A and B). Importantly, the energy expenditure of
Y2!/!Y4!/! mice in the dark phase was not only significantly
higher than that of wild types, also it was significantly higher
than that of Y2!/! and Y4!/! mice (Fig. 2, A and B),
suggesting a synergy between Y2 and Y4 signaling in the
regulation of energy expenditure, which may contribute to their
synergistic effects on adiposity.
Synergistic increase in physical activity by double deletion
of Y2 and Y4 receptors. All groups showed a clear circadian
rhythm in physical activity, with markedly higher activity
levels during the dark period when rodents are most active
(Fig. 3A). Importantly, physical activity, an important factor
influencing energy expenditure, was significantly increased in
Y4!/! but not Y2!/! mice in the dark phase, resulting in an
overall significantly increased daily activity levels in Y4!/!
mice (Fig. 3, A and B). These data demonstrate an important
role of Y4 signaling in the control of physical activity and
suggest that an increase in physical activity may contribute to
the increase in energy expenditure observed in Y4!/! mice.
Interestingly, whereas Y2 receptor single deletion had no
significant effect on physical activity (Fig. 3, A and B), double
deletion of Y2 and Y4 receptors lead to a marked and signif-
icant increase in physical activity relative to wild-type levels
that was also significantly greater than that induced by Y4
receptor deletion per se (Fig. 3, A and B). These data reveal an
indirect control of physical activity by Y2 signaling via a
synergistic interaction with Y4, likely contributing to the
increases in energy expenditure and whole body lean mass
observed in Y2!/!Y4!/! mice.
To determine whether an increase in basal metabolic rate, in
addition to the measured increase in physical activity, may
contribute to the increases in total energy expenditure observed
in Y4!/! and Y2!/!Y4!/! mice, we performed a correlation
analysis between physical activity and energy expenditure.
When hourly data from individual mice were analyzed for
correlations between energy expenditure and physical activity,
there was a positive correlation between the two parameters
(P " 0.05 by Pearson correlation for all animals studied).
Using the function from the trend line and extrapolating to set
the physical activity to zero, we found that the x-axis intercept,
an index of resting metabolic rate (7), was higher in Y4!/! and
particularly in Y2!/!Y4!/! compared with wild-type control
mice, although this increase was not statistically significant
Fig. 2. Synergy between Y2 and Y4 receptors in the regulation of energy
expenditure. Time course of energy expenditure (A) and averages for 24-h,
light and dark phases (B) in WT, Y2!/!, Y4!/!, and Y2!/!Y4!/! mice.
Energy expenditure was adjusted for lean mass via ANCOVA: adjusted energy
expenditure (common lean mass # 19.33 g) was presented. White and black
horizontal bars on A indicate light and dark phase, respectively. Data are
means $ SE of 6–10 mice per group. *P " 0.05, **P " 0.001 vs. WT mice
or comparison indicated by horizontal bars.
Table 2. Nonnormalized energy expenditure (EE, kcal/h) in wild-type, Y2!/!, Y4!/!, and Y2!/!Y4!/! mice
Wild Type Y2!/! Y4!/! Y2!/!Y4!/!
24-hour EE 0.432 $ 0.012 0.405 $ 0.011 0.428 $ 0.013 0.501 $ 0.019*‡§
Light phase EE 0.406 $ 0.012 0.369 $ 0.010 0.381 $ 0.014 0.425 $ 0.021
Dark phase EE 0.459 $ 0.012 0.440 $ 0.013 0.475 $ 0.014 0.577 $ 0.021†‡§
Resting EE 0.340 $ 0.012 0.301 $ 0.014 0.344 $ 0.011 0.387 $ 0.021‡
Resting EE, adjusted for lean mass 0.334 $ 0.012 0.312 $ 0.013 0.355 $ 0.019 0.384 $ 0.022‡
Data are means $ SE of 6–10 mice/group. Data is averaged for 24 h as well as in the light and dark phases, and resting EE (nonnormalized and adjusted for
lean mass), as determined by correlation analysis between energy expenditure and physical activity. ANCOVA was performed on resting metabolic rate using
lean tissue mass as covariate, and the adjusted value was generated on the common lean mass of 19.36 g. *P " 0.05 and †P " 0.001 vs. wild-type mice;
‡P " 0.05 vs. Y2!/! mice; §P " 0.05 vs. Y4!/! mice.
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of oxidative fuel source, by indirect calorimetry with concur-
rent measurement of phys cal activity in wild-type, Y2!/!,
Y4!/!, and Y2!/!Y4!/! mice.
Since energy expenditure is, in p t, determined by body
size, we normalized energy expenditure via ANCOVA (Fig. 2)
to account for differences in lean tissue ass, the best deter-
minant of energy expenditure (37) (see Table 2 for nonnormal-
ized energy expenditure data). Energy expenditure followed a
circadian rhythm in all groups, with higher energy expenditure
in the dark period (Fig. 2A). Y2!/! mice had similar daily
energy expenditure to wild types, with a slight decrease in
energy expenditure during the light period (Fig. 2, A and B). I
contrast, Y4!/! mice showed a significant increase in energy
expenditure compared with wild-type mice during the dark
period (Fig. 2, A and B). Interestingly, mice with double
deletion of Y2 and Y4 receptors showed a marked increase in
overall energy expenditure, which is significant during the dark
period (Fig. 2, A and B). Importantly, the energy expenditure of
Y2!/!Y4!/! mice in the dark phase was not only significantly
higher than that of wild types, also it was significantly higher
than that of Y2!/! and Y4!/! mic (Fig. 2, A and B),
suggesting a synergy between Y2 and Y4 signaling in the
regulation of energy expenditure, which may contribute to their
synergistic effects on adiposity.
Synergistic increase in physical activity by double deletion
of Y2 and Y4 receptors. All groups showed a clear circadian
rhythm in physical activity, with markedly higher activity
levels during the dark period when rodents are most active
(Fig. 3A). Importantly, physical activity, an important factor
influencing energy expenditure, was significantly increased in
Y4!/! but not Y2!/! mice in the dark phase, resulting in an
overall significantly increased daily activity levels in Y4!/!
mice (Fig. 3, A and B). These data demonstrate an important
role of Y4 signaling in the control of physical activity and
suggest that an increase in physical activity may contribute to
the increase in energy expenditure observed in Y4!/! mice.
Interestingly, whereas Y2 receptor single deletion had no
significant effect on physical activity (Fig. 3, A and B), double
deletion of Y2 and Y4 receptors lead to a marked and signif-
icant increase in physical activity relative to wild-type levels
that was also significantly greater than that induced by Y4
receptor deletion per se (Fig. 3, A and B). These data reveal an
indirect control of physical activity by Y2 signaling via a
synergistic interaction with Y4, likely contributing to the
increases in energy expenditure and whole body lean mass
observed in Y2!/!Y4!/! mice.
To determine whether an increase in basal metabolic rate, in
addition to the measured increase in physical activity, may
contribute to the increases in total energy expenditure observed
in Y4!/! and Y2!/!Y4!/! mice, we performed a correlation
a alysis between physical activity and energy expenditure.
When hourly data from indiv dual mice were analyzed for
correlations between energy expenditure and physical activity,
there was a positive correlation betwee the two parameters
(P " 0.05 by Pearson correlation for all animals studied).
Using the function from the trend line and extrapolating to set
the physical activity to zero, we found that the x-axis intercept,
an index of resting metabolic rate (7), was higher in Y4!/! and
particularly in Y2!/!Y4!/! compared with wild-type control
mice, a though this increase was not statistically significant
Fig. 2. Synergy between Y2 and Y4 receptors in the regulation of energy
expenditure. Time course of energy expenditure (A) and averages for 24-h,
light and dark phases (B) in WT, Y2!/!, Y4!/!, and Y2!/!Y4!/! mice.
Energy expenditure was adjusted for lean mass via ANCOVA: adjusted energy
expenditure (common lean mass # 19.33 g) was presented. White and black
horizontal bars on A indicate light and dark phase, respectively. Data are
means $ SE of 6–10 mice per group. *P " 0.05, **P " 0.001 vs. WT mice
or comparison indicated by horizontal bars.
Table 2. Nonnormalized energy expenditure (EE, kcal/h) in wild-type, Y2!/!, Y4!/!, and Y2!/!Y4!/! mice
Wild Type Y2!/! Y4!/! Y2!/!Y4!/!
24-hour EE 0.432 $ 0.012 0.405 $ 0.011 0.428 $ 0.013 0.501 $ 0.019*‡§
Light phase EE 0.406 $ 0.012 0.369 $ 0.010 0.381 $ 0.014 0.425 $ 0.021
Dark phase EE 0.459 $ 0.012 0.440 $ 0.013 0.475 $ 0.014 0.577 $ 0.021†‡§
Resting EE 0.340 $ 0.012 0.301 $ 0.014 0.344 $ 0.011 0.387 $ 0.021‡
Resting EE, adjusted for lean mass 0.334 $ 0.012 0.312 $ 0.013 0.355 $ 0.019 0.384 $ 0.022‡
Data are means $ SE of 6–10 mice/group. Data is averaged for 24 h as well as in the light and dark phases, and resting EE (nonnormalized and adjusted for
lean mass), as determined by correlation analysis between energy expenditure and physical activity. ANCOVA was performed on resting metabolic rate using
lean tissue mass as covariate, and the adjusted value was generated on the common lean mass of 19.36 g. *P " 0.05 and †P " 0.001 vs. wild-type mice;
‡P " 0.05 vs. Y2!/! mice; §P " 0.05 vs. Y4!/! mice.
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Synergistic increase in physical activity by double deletion of Y2 and Y4 receptors. 
All groups showed a clear circadian rhythm in physical activity, with markedly higher activity 
levels during the dark period when rodents are most active (Fig. 3A). Importantly, physical 
activity, an important factor influencing energy expenditure, was significantly increased in 
Y4−/− but not Y2−/− mice in the dark phase, resulting in an overall significantly increased 
daily activity levels in Y4−/− mice (Fig. 3, A and B). These data demonstrate an important role 
of Y4 signaling in the control of physical activity and suggest that an increase in physical 
activity may contribute to the increase in energy expenditure observed in Y4−/− mice. 
Interestingly, whereas Y2 receptor single deletion had no significant effect on physical activity 
(Fig. 3, A and B), double deletion of Y2 and Y4 receptors lead to a marked and significant 
increase in physical activity relative to wild-type levels that was also significantly greater than 
that induced by Y4 receptor deletion per se (Fig. 3, A and B). These data reveal an indirect 
control of physical activity by Y2 signaling via a synergistic interaction with Y4, likely 
contributing to the increases in energy expenditure and whole body lean mass observed in 
Y2−/−Y4−/− mice. 	  
	  
 To determine whether an increase in basal metabolic rate, in addition to the 
measured increase in physical activity, may contribute to the increases in total energy 
expenditure observed in Y4−/− and Y2−/−Y4−/− mice, we performed a correlation analysis 
between physical activity and energy expenditure. When hourly data from individual mice 
were analyzed for correlations between energy expenditure and physical activity, there was a 
positive correlation between the two parameters (P < 0.05 by Pearson correlation for all 
animals studied). Using the function from the trend line and extrapolating to set the physical 
activity to zero, we found that the x-axis intercept, an index of resting metabolic rate (7), was 
higher in Y4−/− and particularly in Y2−/−Y4−/− compared with wild-type control mice, 
although this increase was not statistically significant (Table 2). These data suggest that an 
(Table 2). These data suggest that an increase in basal metab-
olism may be an important contributor to the increased total
energy expenditure observed in Y4!/! and Y2!/!Y4!/! mice.
Altered substrate utilization in response to either Y2 or Y4
receptor deletion. To identify whether alterations in substrate
utilization may contribute to the lean phenotypes of the single
and double Y2 and Y4 knockout models, we measured the
RER of these mice. Y2!/! and Y4!/! mice exhibited signif-
icant red ctions in overall RER red with wild-type mice,
suggesting a greater use of lipid as an oxidative fuel source
and/or reduced lipogenesis (Fig. 4, A and B). Furthermore, Y4
signaling appears to have a greater control on fuel selection
than Y2 signaling, as the decrease in RER during the light
period was more pronounced in Y4!/! than in Y2!/! mice
(Fig. 4, A and B). Interestingly, in contrast to the synergy
between Y2 and Y4 receptors in the control of energy expen-
diture and physical activity, the Y2 and Y4 receptor seem not
to regulate substrate partitioning pathways synergistically, be-
cause, whereas Y2!/!Y4!/! mice had reduced RER compared
with wild types, the pattern and magnitude of this reduction
was similar to that in Y4!/! mice (Fig. 4, A and B). Taken
together, these data demonstrate the critical role Y2 and Y4
receptor signaling in the control of oxidative fuel metabolism
and also suggest an important contribution to increased lipid
oxidation and/or decreased lipogenesis by Y2 and Y4 recep-
tors. However, other mechanisms, such as increased energy
expenditure and physical activity, may play the key role in the
synergistic reduction in adiposity in Y2!/!Y4!/! mice.
Enhanced muscle mitochondrial oxidative capacity in mice
with double deletion of Y2 and Y4 receptors. To investigate
mechanisms by which Y2 and Y4 receptors regulate energy
expenditure, we examined by Western blot analysis the muscle
protein levels of several key molecules involved in mitochon-
drial oxidation, the key cellular processes that convert bio-
chemical energy to a form that can be used for biological work.
Y2!/! and Y4!/! (Fig. 5, A and B) mice were comparable to
wild types with regard to the muscle protein levels of subunits
of the respiratory chain complexes I, II, III, and V, as well as
that of the PGC-1", an important regulator of mitochondrial
biogenesis (28). In contrast, muscle protein levels of subunits
I and III of the respiratory chain complex, as well as that of
PGC-1", were significantly increased in Y2!/!Y4!/! mice
compared with wild types (Fig. 5C), suggesting an increased
mitochondrial oxidative capacity caused by dual deletion of Y2
and Y4 receptors. These data suggest a synergy between Y2
and Y4 signaling in the control of mitochondrial oxidative
capacity and are consistent with the synergistic increase in
energy expenditure measured in Y2!/!Y4!/! mice (Fig. 2).
Interestingly, all knockout mice exhibited a significant increase
relative to wild types in muscle protein levels of CPT-1, the
mitochondrial transmembrane enzyme controlling entry of
Fig. 4. Altered substrate utilization by single or double deletion of Y2 and Y4
receptors. Time course of respiratory exchange ratio (an index of oxidative
fuel) (A) and averages for 24 h, light, and dark phases (B) in WT, Y2!/!,
Y4!/!, and Y2!/!Y4!/! mice. White and black horizontal bars on A indicate
light and dark phase, respectively. Data are means # SE of 6–10 mice per
group. *P $ 0.05, **P $ 0.001 vs. WT mice or comparison indicated by
horizontal bars.
Fig. 3. Synergy between Y2 and Y4 receptors in the regulation of physical
activity. Time course of physical activity (A) and averages for 24-h, light and
dark phases (B) in WT, Y2!/!, Y4!/!, and Y2!/!Y4!/! mice. White and
black horizontal bars on A indicate light and dark phase, respectively. Data are
means # SE of 6–10 mice per group. *P $ 0.05, **P $ 0.001 vs. WT mice
or comparison indicated by horizontal bars.
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increase in basal metabolism may be an important contributor to the increased total energy 
expenditure observed in Y4−/− and Y2−/−Y4−/− mice. 
 
Altered substrate utilization in response to either Y2 or Y4 receptor deletion. 
To identify whether alterations in substrate utilization may contribute to the lean 
phenotypes of the single and double Y2 and Y4 knockout models, we measured the RER of 
these mice. Y2−/− and Y4−/− mice exhibited significant reductions in overall RER compared 
with wild-type mice, suggesting a greater use of lipid as an oxidative fuel source and/or 
reduced lipogenesis (Fig. 4, A and B). Furthermore, Y4 signaling appears to have a greater 
control on fuel selection than Y2 signaling, as the decrease in RER during the light period was 
more pronounced in Y4−/− than in Y2−/− mice (Fig. 4, A and B). Interestingly, in contrast to 
the synergy between Y2 and Y4 receptors in the control of energy expenditure and physical 
activity, the Y2 and Y4 receptor seem not to regulate substrate partitioning pathways 
synergistically, because, whereas Y2−/−Y4−/− mice had reduced RER compared with wild 
types, the pattern and magnitude of this reduction was similar to that in Y4−/− mice (Fig. 4, A 
and B). Taken together, these data demonstrate the critical role Y2 and Y4 receptor signaling 
in the control of oxidative fuel metabolism and also suggest an important contribution to 
increased lipid oxidation and/or decreased lipogenesis by Y2 and Y4 receptors. However, 
other mechanisms, such as increased energy expenditure and physical activity, may play the 
key role in the synergistic reduction in adiposity in Y2−/−Y4−/− mice. 
	  
 
(Table 2). These data suggest that an increase in basal metab-
olism may be an important contributor to the increased total
energy expenditure observed in Y4!/! and Y2!/!Y4!/! mice.
Altered substrate utilization in response to either Y2 or Y4
receptor deletion. To identify whether alterations in substrate
utilization may contribute to the lean phenotypes of the single
and double Y2 and Y4 knockout models, we measured the
RER of these mice. Y2!/! and Y4!/! mice exhibited signif-
icant reductions in overall RER compared with wild-type mice,
suggesting a greater use of lipid as an oxidative fuel source
and/or reduced lipogenesis (Fig. 4, A and B). Furthermore, Y4
signaling appears to have a greater control on fuel selection
than Y2 signaling, as the decrease in RER during the light
period was more pronounced in Y4!/! than in Y2!/! mice
(Fig. 4, A and B). Interestingly, in contrast to the synergy
between Y2 and Y4 receptors in the control of energy expen-
diture and physical activity, the Y2 and Y4 receptor seem not
to regulate substrate partitioning pathways synergistically, be-
cause, whereas Y2!/!Y4!/! mice had reduced RER compared
with wild types, the pattern and magnitude of this reduction
was similar to that in Y4!/! mice (Fig. 4, A and B). Taken
together, these data demonstrate the critical role Y2 and Y4
receptor signaling in the control of oxidative fuel metabolism
and also suggest an important contribution to increased lipid
oxidation and/or decreased lipogenesis by Y2 and Y4 recep-
tors. However, other mechanisms, such as increased energy
expenditure and physical activity, may play the key role in the
synergistic reduction in adiposity in Y2!/!Y4!/! mice.
Enhanced muscle mitochondrial oxidative capacity in mice
with double deletion of Y2 and Y4 receptors. To investigate
mechanisms by which Y2 and Y4 receptors regulate energy
expenditure, we examined by Western blot analysis the muscle
protein levels of several key molecules involved in mitochon-
drial oxidation, the key cellular processes that convert bio-
chemical energy to a form that can be used for biological work.
Y2!/! and Y4!/! (Fig. 5, A and B) mice were comparable to
wild types with regard to the muscle protein levels of subunits
of the respiratory chain complexes I, II, III, and V, as well as
that of the PGC-1", an important regulator of mitochondrial
biogenesis (28). In contrast, muscle protein levels of subunits
I and III of the respiratory chain complex, as well as that of
PGC-1", were significantly increased in Y2!/!Y4!/! mice
compared with wild types (Fig. 5C), suggesting an increased
mitochondrial oxidative capacity caused by dual deletion of Y2
and Y4 receptors. These data suggest a synergy between Y2
and Y4 signaling in the control of mitochondrial oxidative
capacity and are consistent with the synergistic increase in
energy expenditure measured in Y2!/!Y4!/! mice (Fig. 2).
Interestingly, all knockout mice exhibited a significant increase
relative to wild types in muscle protein levels of CPT-1, the
mitochondrial transmembrane enzyme controlling entry of
Fig. 4. Altered substrate utilization by single or double deletion of Y2 and Y4
receptors. Time course of respiratory exchange ratio (an index of oxidative
fuel) (A) and averages for 24 h, light, and dark phases (B) in WT, Y2!/!,
Y4!/!, and Y2!/!Y4!/! mice. White and black horizontal bars on A indicate
light and dark phase, respectively. Data are means # SE of 6–10 mice per
group. *P $ 0.05, **P $ 0.001 vs. WT mice or comparison indicated by
horizontal bars.
Fig. 3. Synergy between Y2 and Y4 receptors in the regulation of physical
activity. Time course of physical activity (A) and averages for 24-h, light and
dark phases (B) in WT, Y2!/!, Y4!/!, and Y2!/!Y4!/! mice. White and
black horizontal bars on A indicate light and dark phase, respectively. Data are
means # SE of 6–10 mice per group. *P $ 0.05, **P $ 0.001 vs. WT mice
or comparison indicated by horizontal bars.
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Enhanced muscle mitochondrial oxidative capacity in mice with double deletion of Y2 and Y4 
receptors. 
To investigate mechanisms by which Y2 and Y4 receptors regulate energy 
expenditure, we examined by Western blot analysis the muscle protein levels of several key 
molecules involved in mitochondrial oxidation, the key cellular processes that convert 
biochemical energy to a form that can be used for biological work. Y2−/− and Y4−/− (Fig. 5, A 
and B) mice were comparable to wild types with regard to the muscle protein levels of 
subunits of the respiratory chain complexes I, II, III, and V, as well as that of the PGC-1α, an 
important regulator of mitochondrial biogenesis (28). In contrast, muscle protein levels of 
subunits I and III of the respiratory chain complex, as well as that of PGC-1α, were 
significantly increased in Y2−/−Y4−/− mice compared with wild types (Fig. 5C), suggesting an 
increased mitochondrial oxidative capacity caused by dual deletion of Y2 and Y4 receptors. 
These data suggest a synergy between Y2 and Y4 signaling in the control of mitochondrial 
oxidative capacity and are consistent with the synergistic increase in energy expenditure 
measured in Y2−/−Y4−/− mice (Fig. 2). Interestingly, all knockout mice exhibited a significant 
increase relative to wild types in muscle protein levels of CPT-1, the mitochondrial 
transmembrane enzyme controlling entry of fatty acid into mitochondria, and the rate-limiting 
enzyme for fatty acid oxidation (33, 39), with no synergistic effects observed in Y2−/−Y4−/− 
mice (Fig. 5). These data suggest an increased capacity to transport fatty acids into 
mitochondria for oxidation in mice lacking either one or both of the Y2 and Y4 receptor, likely 
contributing to the increased lipid oxidation indicated by the reduced RER seen in Y2−/−, 
Y4−/−, and Y2−/−Y4−/− mice. 
	  	  
 
fatty acid into mitochondria, and the rate-limiting enzyme for
fatty acid oxidation (33, 39), with no synergistic effects ob-
served in Y2!/!Y4!/! mice (Fig. 5). These data suggest an
increased capacity to transport fatty acids into mitochondria for
oxidation in mice lacking either one or both of the Y2 and Y4
receptor, likely contributing to the increased lipid oxidation
indicated by the reduced RER seen in Y2!/!, Y4!/!, and
Y2!/!Y4!/! mice.
DISCUSSION
This study shows that signaling through Y2 and Y4 recep-
tors is critical for the regulation of body composition, energy
expenditure, and physical activity, since lack of Y2 and Y4
receptors in mice results in a striking and synergistic reduction
in adiposity (particularly intra-abdominal adiposity) and a
marked increase in lean body mass (nonfat nonbone mass as
determined by DXA) with no significant change in food intake,
concomitant with marked and significant synergistic increases
in energy expenditure and physical activity. Moreover, these
findings reveal a direct role of Y4 signaling and a synergistic
interaction with Y2 signaling in the regulation of energy
expenditure and physical activity, whereas Y2 and Y4 signal-
ing each play important roles in the regulation of substrate
utilization without synergistic action. Double deletion of Y2
Fig. 5. Mitochondrial oxidation in Y2!/! (A), Y4!/! (B), and
Y2!/!Y4!/! (C) mice. Protein levels of subunits I, II, III, and
V of the mitochondrial respiratory chain complex, peroxisome
proliferator-activated receptor (PPAR)" coactivator !1#
(PGC-1#), and carnitine palmitoyltransferase-1 (CPT-1) in the
skeletal muscle. Data are means $ SE of 5–8 mice per group
and are expressed as % wild-type values. *P % 0.05 vs. WT.
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DISCUSSION 
 This study shows that signaling through Y2 and Y4 receptors is critical for the 
regulation of body composition, energy expenditure, and physical activity, since lack of Y2 
and Y4 receptors in mice results in a striking and synergistic reduction in adiposity 
(particularly intra-abdominal adiposity) and a marked increase in lean body mass (nonfat 
nonbone mass as determined by DXA) with no significant change in food intake, concomitant 
with marked and significant synergistic increases in energy expenditure and physical activity. 
Moreover, these findings reveal a direct role of Y4 signaling and a synergistic interaction with 
Y2 signaling in the regulation of energy expenditure and physical activity, whereas Y2 and Y4 
signaling each play important roles in the regulation of substrate utilization without synergistic 
action. Double deletion of Y2 and Y4 receptors leads to significant increases in muscle 
protein levels of subunits I and III of the respiratory chain complex as well as that of PGC-1α 
that are not seen in mice with single knockouts, suggesting that Y2 and Y4 signaling may 
interact to regulate mitochondrial oxidative capacity and thereby contributing to the synergistic 
increase in energy expenditure and decrease in fat mass seen in Y2−/−Y4−/− mice. 
 Lack of Y2 signaling has been shown to provide protection against obesity induced by 
corticosterone infusion (43), a high-fat diet (41), Y1 receptor deficiency (41), or leptin 
deficiency (44). Our new data now show that the protection conferred by Y2 receptor deletion 
against obesity is not likely to come from changes in energy expenditure or physical activity, 
as Y2−/− mice had similar overall energy expenditure and physical activity to that of wild-type 
controls. In keeping with the lack of increase in overall energy expenditure in Y2−/− mice, 
chronic central activation of Y2 receptors by the Y2 receptor agonist Ac-NPY(24–36)(Leu28, 
Leu30) did not change oxygen consumption (18). Interestingly, our study shows that Y2−/− 
mice had a slight but significant decrease in RER during the light phase, indicating an 
increased lipid oxidation and/or decreased lipogenesis. It should be noted that energy 
balance is a factor influencing RER (32), and our Y2−/− mice showed a trend toward 
decreased daily food intake. Although energy expenditure during the light period is also 
decreased in Y2−/− mice, it is possible that Y2−/− mice are in energy deficiency at least 
during some of the 24-h day, and this may contribute to the lower body weight, the lean 
phenotype, and also the reduced RER seen in these mice. However, the increased muscle 
protein levels of CPT-1, an increase that enhances lipid oxidation (11), in the muscle of Y2−/− 
mice support a primary role of Y2 signaling on substrate utilization. Importantly, this change in 
substrate utilization in conjunction with other actions induced by Y2 receptor deletion such as 
stimulation of the somatotropic axis (29, 44) may contribute to the anti-obesity effects of Y2 
receptor ablation. Indeed, it has recently been shown that activation of Y2 receptors by NPY 
stimulates fat angiogenesis and adipogenesis in preadipocytes primed for differentiation and 
promotes adipoctye proliferation (25). Thus it appears likely that Y2 receptor signaling 
controls nutrient uptake in adipose tissue and promotes lipogenesis. Lack of Y2 receptor 
signaling therefore results in reduced white adipose tissue mass with coinciding increases in 
nonfat tissues such as bone, the latter effect being due to increased osteoblast activity and an 
increased rate of bone mineralization and formation (4). Taken together, our current data 
suggest that Y2 signaling plays a role in the regulation of fuel selection but not in the control 
of energy expenditure or physical activity, and that the protection against obesity upon Y2 
receptor deletion is more likely the result of altered substrate utilization and energy 
partitioning between fat and lean mass. 
 In contrast to the lack of effect of Y2 receptor ablation on energy expenditure and 
physical activity, our study demonstrates a prominent role of Y4 signaling in the regulation of 
these processes. Interestingly, Y2 signaling appears to interact and enhance the effects 
mediated by Y4 signaling, since energy expenditure and physical activity is significantly more 
increased in Y2−/−Y4−/− than in Y4−/− mice. The synergistic effects on energy expenditure 
induced by Y2 and Y4 receptors may be mediated at least in part by their concomitant 
synergistic actions on physical activity. Furthermore, we showed that increased basal 
metabolic rate may also contribute to the increased total energy expenditure in mice lacking 
Y4 receptors. This is consistent with the increase in activity of the hypothalamo-pituitary-
thyroid axis that has been reported in Y4−/− and Y2−/−Y4−/− mice (40), thyroid function being 
an important regulator of metabolic rate (6, 48). Furthermore, the daily food intake in 
Y2−/−Y4−/− mice tended to be higher than that of wild types, in contrast to a trend toward a 
lower food intake in Y2−/− or Y4−/− mice relative to wild types. It is important to note that 5–
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10% differences in daily food intake can have a significant impact on body weight and body 
composition over the long term, and such small differences in daily food intake may not be 
detectable or reach statistical significance when measurement is performed over a short 
period of time such as the 3 days in the current study. Thus, whereas it is possible that a 
decrease in daily food intake in Y2−/− and Y4−/− mice may contribute to the decreased body 
weight and lean phenotype in these mice, the synergistic increase in energy expenditure 
induced by Y2 and Y4 receptor double deletion likely plays a critical role in the synergistic 
reduction in adiposity seen in Y2−/−Y4−/− mice. Moreover, it is interesting to note that a high 
energy turnover balance (i.e., higher energy intake and expenditure with maintained energy 
balance) has recently been shown to influence metabolism differently from low energy 
turnover balance, at least in the short term (12), which could conceivably have implications for 
the long-term regulation of body weight and composition. Although the energy balance status 
wasn't directly assessed in the present study, the trend to a higher daily food intake and 
significantly greater energy expenditure in Y2−/−Y4−/− mice is consistent with a higher 
energy flux, and this could mediate some of the metabolic effects seen in these mice. 
Interestingly, whereas increased lipid oxidation may contribute to the lean phenotype of 
Y2−/−Y4−/− mice, it is unlikely to play a key role in mediating the synergy between Y2 and Y4 
signaling in the regulation of fat mass, as the reduction in RER, indicating increased lipid 
oxidation and/or decreased lipogenesis, as well as the increase in muscle protein levels of 
CPT-1, a key regulator of mitochondrial lipid oxidation, was comparable between Y2−/−Y4−/− 
and Y2−/− or Y4−/− mice. In conclusion, our data show the critical roles of Y4 signaling in the 
regulation of energy metabolism, physical activity, and substrate oxidation, with synergistic 
interactions with Y2 signaling in the control of energy expenditure and physical activity but not 
substrate oxidation, likely contributing to the synergistic reduction in adiposity observed in 
Y2−/−Y4−/− mice. 
 An increased capacity for mitochondrial oxidation, indicated by the significant and 
synergistic increase in the muscle protein levels of PGC-1α and subunits I and III of the 
respiratory chain complex in Y2−/−Y4−/− mice, may be mechanistically involved in the 
synergistic increase in total energy expenditure, and may particularly contribute to the 
increased basal metabolic rate seen in these animals. Furthermore, the altered substrate 
utilization favoring fat burning induced by single or double deletion of Y2 and Y4 receptors 
may be mediated by an increased capacity for fatty acid transport into mitochondria, as 
indicated by the significantly increased muscle protein levels of CPT-1, since overexpression 
of CPT-1 in skeletal muscle enhances fatty acids influx into mitochondria and increases lipid 
oxidation (10). It is unclear, however, whether Y2 and Y4 signaling regulates these 
mitochondrial functions via direct or indirect, peripheral or central mechanisms. The significant 
increases in muscle protein levels of PGC-1α in Y2−/−Y4−/− mice is in line with an indirect 
mechanism via Y2 and Y4 signaling-induced effects on physical activity, since PGC-1α is a 
downstream target of exercise (1, 51) and an important regulator of mitochondrial biogenesis 
and oxidative capacity as well as substrate oxidation (9, 28, 54). It is interesting to note, 
however, that, whereas Y4−/− mice also showed increased physical activity, muscle capacity 
for mitochondrial oxidation was not increased, at least when assessed by the protein 
expression levels of molecules involved in mitochondrial oxidation. Thus it appears likely that 
the further increase in physical activity induced by the Y2 deletion in addition to Y4 is required 
to increase mitochondrial oxidative capacity. A central mechanism of effect on physical 
activity, as similarly suggested for Y1 receptors (56), may mediate the primary control by Y4 
signaling and synergistic interaction with Y2 signaling on physical activity. On the other hand, 
regulation by Y2 receptors of the capacity for fatty acid transport into mitochondria likely 
involved a peripheral mechanism, since deletion of Y2 receptor in hypothalamic NPY-ergic 
neurons results in decreased rather than increased muscle protein level of CPT-1 (47). 
The profound reduction in fat mass seen in our in Y2−/−Y4−/− mice is associated with a 
marked increase in lean mass, as determined by DXA, in the absence of any change in body 
weight. In conjunction with our previous report showing a synergy between Y2 and Y4 
signaling to increase bone mass (40), these findings suggest the formation of lean and bone 
mass at the expense of fat mass in the absence of Y2 and Y4 signaling. Energy redistribution 
from fat to lean tissues via Y2 receptors as discussed above may contribute significantly to 
the observed synergistic effects on body composition in Y2−/−Y4−/− mice. Furthermore, 
although Y4 receptor deletion alone did not alter bone metabolism (40), Y4 deletion may 
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contribute to the effect of Y2 receptor deletion on lean mass and bone mass by increasing 
physical activity, which is known to modulate muscle mass and stimulate bone growth (13, 
14). 
 Whereas our findings suggest that dual antagonism of Y2 and Y4 receptors may 
provide potent anti-obesity effects while also promoting lean body mass and bone mass, it is 
noteworthy that PYY3–36 and PP, the endogenous agonists for Y2 and Y4 receptors, 
respectively, have been proposed as anti-obesity agents due to their inhibitory effects on food 
intake and gastric emptying (5, 38, 46). Additionally, there are reports of increased energy 
expenditure in response to acute PYY3–36 or PP administration (2, 49). However, this effect 
of Y2 or Y4 receptor agonism appears to be transient, as no increase in energy expenditure 
was observed after long-term elevation of PYY3–36 or PP levels by chronic administration or 
overexpression (52, 53). Our study on knockout mouse model suggests that long-term dual 
Y2 and Y4 receptor antagonism may increase energy expenditure. More importantly, dual Y2 
and Y4 receptor antagonism reduces fat mass with concomitant increases in lean tissue 
mass, in contrast to the decrease in lean tissue mass often observed during weight/fat loss 
(21). Moreover, the more prominent reduction in intra-abdominal vs. subcutaneous fat 
induced by dual Y2 and Y4 receptor antagonism as seen in this study may confer a greater 
metabolic benefit than that of overall fat loss, since subcutaneous fat has been suggested to 
have protective effects on insulin sensitivity and glucose tolerance (20) and since waist-to-hip 
ratio, influenced by the ratio of intra-abdominal to subcutaneous fat, is emerging as a better 
predictor of health than central adiposity alone (30). Finally, as discussed previously, a 
peripheral-acting Y2 antagonist and a central-acting Y4 antagonist may be an effective 
combination as anti-obesity therapeutics. 
 
Perspectives and Significance 
This is the first work investigating the individual control and coordinated interactions 
between Y2 and Y4 signaling in the regulation of energy metabolism using indirect 
calorimetry. This study shows that Y4 signaling is critically involved and synergistically 
interacts with Y2 signaling in the regulation of energy expenditure and physical activity, 
whereas Y2 and Y4 signaling may each exert important roles in the control of oxidative fuel 
selection without significant interaction. These coordinated actions lead to greater reductions 
in adiposity with concomitant greater increases in lean tissue mass in Y2−/−Y4−/− mice than 
the changes seen in response to deletion of either receptor alone. One limitation of this study 
is that, whereas daily food intake was determined using a refined protocol that accounted for 
food spillage and was measured in mice of the same age, it was only measured over three 
consecutive days. As such, small difference in daily food intake that could have significant 
effects on body weight over a longer period of time may not have been detectable. However, 
the trend to an increase in food intake in Y2−/−Y4−/− mice suggests that the significant 
increase in energy expenditure and/or a high energy turnover seen in these mice may play a 
critical role in mediating the lean phenotype induced by ablation of both Y2 and Y4 receptors. 
We further show that an increased capacity for mitochondrial oxidation and fatty acid 
transport may be mechanistically involved to increase energy expenditure and alter substrate 
utilization favoring fat burning in mice with Y2 and Y4 receptor double deletion. However, it 
remains to be determined whether Y2 and Y4 signaling regulates these mitochondrial 
functions via direct or indirect, peripheral or central mechanisms. Conditional and tissue-
specific Y2 and/or Y4 receptor knockout models will be needed to further investigate this 
effect. Importantly however, our findings highlight the possibility that dual antagonism of Y2 
and Y4 receptors may offer a potent and effective adjunct in the treatment of obesity. 
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